baber/WOPTO huggingface dataset:
Patent DE-69128810-T2 (DE)
Inventor: TSUJI SADAHIKO
IPC: G02B27/28
Filed: 1991-05-03
Granted: 1998-05-28
Abstract: This specification discloses a polarization converting apparatus having means emitting non-polarized light, and polarizing means having a light incidence surface and a light emergence surface, the polarizing means receiving the non-polarized light by the light incidence surface and causing polarized light to emerge from the light emergence surface, the size and shape of the light incidence surface being similar to the size and cross-sectional shape of the non-polarized light. The specification also discloses an optical instrument having such apparatus. <IMAGE>
Patent DE-69129699-T2 (DE)
Inventor: HUTSON WILLIAM H
IPC: H04B1/10
Filed: 1991-12-13
Granted: 1999-04-08
Abstract: A multi-dimensional processing and display system is used with a sonar tracking system to monitor ocean-going vessels. The system arranges data in a three-dimensional matrix, which is then reformatted into a two-dimensional matrix. The two-dimensional matrix is decomposed into singular vectors and singular values. Certain data elements in the two-dimensional matrix are enhanced or diminished by modifying selected angular values. A history database is maintained by saving certain of the singular vectors, which is concatenated with the two-dimensional matrix. An enhanced two-dimensional matrix is generated by multiplying the two-dimensional concatenated matrix by the modified singular values and the singular vectors. After data enhancement, the two-dimensional enhanced matrix is reformatted back into a three-dimensional matrix. All or portions of the enhanced three-dimensional matrix can then be displayed.
Patent DE-69204606-T2 (DE)
Inventor: MITCHELL JAMES D
IPC: D06L3/02
Filed: 1992-06-24
Granted: 1996-02-01
Abstract: The invention provides a cleaning agent and method for removing stains from fabrics comprising a combination of dense gas, a source of hydrogen peroxide and an organic bleach activator therefor. <IMAGE>
Patent DE-69208971-T2 (DE)
Inventor: REYMONET JEAN-PIERRE
IPC: E01C19/17
Filed: 1992-08-06
Granted: 1996-09-19
Abstract: The invention relates to a mechanical actuation device (1) for opening or closing a valve of at least one spray nozzle (2, 2A) moving along a predetermined path with respect to a support (4), the said valve comprising a control member (5, 21) which can move between two positions, an opening one and a closing one, the said device (1) comprising means (7A, 7B, 13A, 13B; 23, 24) intended for mechanically stressing the said control member (5, 21) in order to make it pass from one of its opening or closing positions to the other. 
<??>The valve is of the slide type, the control member (5, 21) being mounted in a sliding manner with respect to the nozzle (2, 2A) in order to be moved in translation between its two opening and closing positions, the stressing means (7A, 7B, 13A, 13B; 23, 24) comprising at least one guiding incline (13A, 13B; 23, 24) provided, in the region of the opening or closing zone, with a break (15A, 15B; 25, 26) by means of which the control member (5, 21) is intended to pass from one of its positions to the other. 
<IMAGE>
Patent DE-69232956-T2 (DE)
Inventor: BARBOUR GEORGE
IPC: C12Q1/68
Filed: 1992-10-22
Granted: 2003-10-02
Abstract: Methods of diagnosing borreliosis, Lyme disease, by detecting the presence of a Borrelia burgdorferi organism in a specimen from an animal, including a human, by the use of PCR-DNA analysis, where the primers are subsequences from OspA and OspB DNA sequences from any of the three B. burgdorferi strains: B31, Ip90 (or Iper90) and ACAI. The method may be used for detecting the presence of B. burgdorferi in a specimen irrespective of the species and strain of the B. burgdorferi organism proposed to be in the specimen, but may also be used for detecting specific strains, depending on the primers chosen. Vaccines comprising polypeptides capable of evoking an immune response against OspA or OspB of B. burgdorferi organisms for active immunization. DNA sequences encoding the polypeptides.
Patent DE-69233213-T2 (DE)
Inventor: IMURA HIROO
IPC: C07K14/00
Filed: 1992-07-10
Granted: 2004-07-01
Abstract: A method for screening an antagonist of the human endothelin receptor so as to identify and study agents of the circulatory system, comprising the steps of contacting a sample comprising a protein receptor with a candidate compound, the protein receptor having high affinity for human ET-1 and ET-2 and lower affinity for human ET-3 and an amino acid sequence from Asp at +1 to Asn at + 407 as shown in SEQ ID NO: 1, and detecting the binding of the candidate compound to the protein receptor. The agent of the circulatory system can used in the manufacture of medicament for treatment of essential hypertension, vasospastic stenocardia, acute myocardial infarction, chronic renal insufficiency, subarachnoid hemorrhage and hypoxia. <IMAGE>
Patent DE-69303425-T2 (DE)
Inventor: NERI CARLO
IPC: C08L55/00
Filed: 1993-04-21
Granted: 1996-11-28
Abstract: Polysiloxanic compounds, containing sterically hindered phenol groups and oxamidic groups in the molecule, obained by the copolymerization of monomers having general formula (I):    (R<1>)n(R<2>)3-nSi-R<3>   (I>  with monomers having general formula (II): <CHEM>
Patent DE-69309700-T2 (DE)
Inventor: SVENSSON STIG-AKE
IPC: B65D88/12
Filed: 1993-09-24
Granted: 1997-11-13
Abstract: A method and apparatus for the transportation of vehicles, primarily cars, by a seagoing vessel. The vehicles are loaded onto cassettes that include at least one floor or story, with each floor or story including a vehicle driveway. The cassettes are loaded by driving the vehicles onto a ramp, or the like, and onto the driveway. The vehicles are positioned one behind the other until the cassette has been loaded with the desired number of vehicles. The cassette is then transported onto the vessel. The vehicles are offloaded in the reverse order so that the cassette is first transported from the vessel to the dock, and the vehicles are driven from the cassette with the aid of a ramp, or the like.
Patent DE-69334077-T2 (DE)
Inventor: MAHANY RONALD
IPC: H04L12/28
Filed: 1993-12-23
Granted: 2007-05-10
Abstract: A transceiver apparatus (110) for creating a wireless personal local area network between a computer terminal (7) and one or more peripheral devices (9, 13, 23). A separate transceiver (110) is connected to the computer terminal (7) and to each peripheral device (9, 13, 23). The transceivers (110) can be connected to the terminal (7) or the peripheral devices (9, 13, 23) either internally or externally. A low power radio (112) is used to communicate information between the computer terminal (7) and the peripheral devices (9, 13, 23). Different transceivers (110) can be used for modifying the carrier frequency and power of the local area network. A microprocessor (120) is located inside each transceiver (110) and controls the information flow of the transceiver including the communication protocol which allows each device (7, 9, 13, 23) to know if other devices (7, 9, 13, 23) are communicating, which devices (7, 9, 13, 23) are being communicated to, and selectively address the peripheral devices (9, 13, 23). An Idle Sense communication protocol is used for information transfer between the computer terminal (7) and the peripheral devices (9, 13, 23).
Patent DE-69401800-T2 (DE)
Inventor: STARCK THIERRY
IPC: H01B17/26
Filed: 1994-07-26
Granted: 1997-06-05
Abstract: Current bushing for a medium-voltage cell, produced by the overmoulding of an insulating resin around a straight metal conductor (2) possessing connection regions at its ends (2A, 2B), the said bushing comprising an axial body (1) around the said conductor and a substantially cylindrical receptacle (4) moulded together with the said cylindrical body, the said receptacle including a flat bottom (4') and a cylindrical lateral skirt (4'') extending coaxially with the said body (1), the said bottom being substantially located at one (2B) of the ends for connecting the said conductor, characterised in that the said axial body (1) extends above the upper level of the skirt of the receptacle (4) over a distance substantially equal to the rated-voltage clearance of the cell. <IMAGE>
Patent DE-69407106-T2 (DE)
Inventor: LISSANDRE MICHEL
IPC: B66C23/82
Filed: 1994-06-03
Granted: 1998-03-26
Abstract: The invention relates to the mounting of the working jib (7) and of the associated counterbalancing jib (8) of tower cranes, used on building and civil engineering work construction sites. The jib elements (15,16,17,18) are aligned and assembled on the ground with their stay (13), then the jib stay (13) and, possibly, the one (111) belonging to the counterbalancing jib (8) is or are lifted up and aligned with the aid of an auxiliary item of mounting plant (69). Next, using the same item of plant (69), the whole of the jib (7) or of the counterbalancing jib (8) together with its stay (13,111) lifted up and aligned is raised and is offered up facing the top of the tower (6) so that the free ends (56,122) of the stays (13,111) are offered up correctly to the very top of the head of the tower (6) to allow direct connection (at 14,138). This method improves safety, and it decreases the duration for which the auxiliary item of mounting plant (69) is immobile. <IMAGE>
Patent DE-69417916-T2 (DE)
Inventor: GUSTAFSSON ANDERS
IPC: A61F13/49
Filed: 1994-12-08
Granted: 1999-09-16
Abstract: PCT No. PCT/SE94/01179 Sec. 371 Date Jul. 29, 1996 Sec. 102(e) Date Jul. 29, 1996 PCT Filed Dec. 8, 1994 PCT Pub. No. WO95/16419 PCT Pub. Date Jun. 22, 1995A diaper having a front part (12), a back part (14) and an intermediate crotch part (13) which includes an absorbent body (1) joined to a fluid-impermeable bottom sheet (7) and a fluid-permeable top sheet (9) which lies proximal to the wearer's body in use and which includes an opening (15) situated in the back and crotch part of the diaper and elastic devices (20, 21) and which is unattached to the absorbent body at least within the region of the opening (15). Two elastic devices (20, 21) in the top sheet (9) extend divergently in relation to one another, from the front edge (16) of the opening (15) in the crotch part (13) towards the back part (14) and on respective sides of the opening in the top sheet (9).
Patent DE-69418650-T2 (DE)
Inventor: DONNADIEU THIERRY
IPC: A43B23/02
Filed: 1994-06-14
Granted: 1999-12-02
Abstract: The sports shoe comprises an upper (11) equipped with an opening (11a), to permit the passage of the foot, and including an inner quarter (12) and an outer quarter (13) which are linked together by means of a lace or cable (15) in conjunction with a blocking device or blocker (20) along a specific alternating path around a return or loops (1 to 8) arranged on both sides of the said opening (11a). According to the invention, the ends of the strands (15a, 15b) forming the lace (15) are secured to two fixed anchoring points (A, B, C, D, E, F, G, H) produced in a lower end zone of the lacing located towards the front (AV) of the shoe, the said strands (15a, 15b) together forming, at their opposite end, a free loop (21) capable of constituting a single gripping element for exerting traction according to a force (F) distributed symmetrically over each of the strands (15a, 15b) from the two fixed points. <IMAGE>
Patent DE-69425292-T2 (DE)
Inventor: AKAZAWA MITSUJI
IPC: A61K31/445
Filed: 1994-04-21
Granted: 2000-11-30
Abstract: An external anti-inflammatory and analgesic plaster preparation includes as an active ingredient a salt of diclofenac, 2[(2,6-dichlorophenyl)amino]benzene-acetic acid, with a cyclic organic having the general formula (I): <CHEM> wherein X is a group of the formula -(CH2)m- in which m is an integer of 0 or 1 and n is an integer of 2 and a pH value of the preparation is adjusted to a range of 7.3 to 9.0.
Patent DE-69425637-T2 (DE)
Inventor: BUZZETTI FRANCO
IPC: A61K31/404
Filed: 1994-05-26
Granted: 2001-05-03
Abstract: Oxindole, acrylamide, thioacrylamide and acrylonitrile compounds, and their pharmaceutically acceptable salts, which are useful as tyrosine kinase inhibitors.
Patent DE-69429580-T2 (DE)
Inventor: VITELLI RENATO
IPC: B02C17/14
Filed: 1994-09-26
Granted: 2002-09-19
Abstract: PCT No. PCT/IT94/00154 Sec. 371 Date Mar. 27, 1996 Sec. 102(e) Date Mar. 27, 1996 PCT Filed Sep. 26, 1994 PCT Pub. No. WO95/09043 PCT Pub. Date Apr. 6, 1995Basket for machines for mixing and grinding a number of substances in order to produce uniform mixes, such as those used for paints, with the basket in question featuring along its perimeter a circular ring (1) bound at the inner and outer edges by micro-perforated walls (2 and 3), and with this ring functioning as a channel inside of which microspheres made of glass or of other suitable materials are placed; the central portion of the basket, when viewed from below, appears empty in the middle, with this space being bound along its perimeter by the circular channel (1).
Patent DE-69506500-T2 (DE)
Inventor: JAMES WILLIAM A
IPC: B23K26/08
Filed: 1995-09-15
Granted: 1999-07-08
Abstract: A topographical support member (2) and method of forming a topographical support member (2) for use in producing nonwoven fabrics, especially tricot-like nonwoven fabrics. The topographical support member (2) includes a body (1) having a top surface (3) comprising a pattern of a plurality of peaks (5) and valleys (6) and a plurality of apertures (7). The apertures (7) have a conical top portion (7a) that is surrounded by a cluster of the peaks (5) and valleys (6). The center line to center line spacing of adjacent apertures (7) is less than the major diameter of the conical top portion (7a) of the apertures (7). The topographical support member (2) is formed by focusing a laser beam so that the focal point is below the top surface (3) of a starting workpiece (1) and drilling with the laser beam the predetermined pattern of tapered apertures (7). The pattern of tapered apertures (7) forms the cluster of peaks (5) and valleys (6) surrounding each aperture (7) on the top surface (3) of the resulting support member (2). <IMAGE>
Patent DE-69534845-T2 (DE)
Inventor: NEWKOME GEORGE R
IPC: C09K23/30
Filed: 1995-07-19
Granted: 2006-10-26
Abstract: A lock unimolecular micelle includes at least one engineered acceptor specifically binding a ligand (or specifically a "key" unimolecular micelle) thereto. A key unimolecular micelle comprises a core molecule and a plurality of branches extending therefrom, at least one of the branches including a shank portion extending therefrom having a terminal moiety at an end thereof for binding to a complimentary acceptor of a lock unimolecular micelle. Together, the lock and key micelles form a unit, either irreversibly or reversibly bound wherein the lock micelles is a soluble receptor engineered to specifically bind to the specifically engineered key micelle.
Patent DE-69535123-T2 (DE)
Inventor: BROOKER GARY
IPC: H04B10/04
Filed: 1995-11-01
Granted: 2007-02-01
Abstract: Methods and apparatuses for high-speed control of lamp intensity and for high-speed optical data communication are disclosed. In particular embodiments, an arc, plasma or halogen lamp is provided with the ability to change wavelengths and/or intensities at high rates (up to 10 gigahertz) by maintaining materials which may be solid or liquid under typical lamp operation or storage conditions in the vapor state. This method and apparatus is particularly applicable to microscopy and high-speed optical data communication, particularly at wavelengths in the visible and ultraviolet spectra.
Patent DE-69535467-T2 (DE)
Inventor: CHADER GERALD J
IPC: C12R1/19
Filed: 1995-06-06
Granted: 2008-01-03
Abstract: Nucleic acids encoding the neurotrophic protein known as pigment epithelium-derived factor (PEDF), a truncated version of PEDF referred to as rPEDF, and equivalent proteins, vectors comprising such nucleic acids, host cells into which such vectors have been introduced, recombinant methods for producing PEDF, rPEDF, and equivalent proteins, the rPEDF protein and equivalent proteins of rPEDF and PEDF -BP, -BX and BA, and the PEDF protein produced by recombinant methods. Effects and use of these variants on: 1) neuronal differentiation (neurotrophic effect), 2) neuron survival (neuronotrophic effect), and 3) glial inhibition (gliastatic effect) are described.
Patent DE-69535694-T2 (DE)
Inventor: SOHN ZEV
IPC: A61M60/126
Filed: 1995-05-02
Granted: 2009-02-05
Abstract: Medical apparatus includes an external drive magnet mounted for rotation externally of a subject's body, an implantable driven magnet configured and dimensioned to be implantable in the subject's body and mounted for rotation by magnetic coupling with the drive magnet and an implantable device mechanically coupled to the driven magnet to be driven thereby. The driven magnet is mountable for rotation in the subject's body about an axis of rotation which is not collinear with the axis of rotation of the external drive magnet such that the magnetic poles of the external drive magnet are magnetically coupled sequentially with the magnetic poles of the implanted driven magnet to rotate the implanted driven magnet, thereby providing flexibility in the location, design and dimensions of the implanted driven magnet, and in the speed and torque ratios between the two magnets.
Patent DE-69608104-T2 (DE)
Inventor: BEK B
IPC: A61B18/12
Filed: 1996-06-03
Granted: 2001-02-01
Abstract: An electrosurgical generator is disclosed that includes an exit spark control system. Exit sparking occurs when energy arcs to the patient as the active electrode is withdrawn from the patient. A basis for controlling the exit spark is to automatically change the frequency at which the final amplifier is driven whenever the conditions for an exit spark are detected. The change in frequency acts to lower the gain and efficiency in the final amplifier and dissipate energy as heat. The exit spark control system includes a frequency adjustable waveform generator and a logic capability for determining the conditions when exit sparking is likely to occur. Sensors and an algorithm in a microcontroller are preferably required to detect the conditions preceding exit sparking occurrence. It is further preferred that, the algorithm also control the sequencing of events: first stopping the electrosurgical output to prevent an arc from initiating and then changing the driving frequency appropriately to dissipate excess stored energy. The output waveform may be stopped for only a short time or the surgeon will detect drag while cutting through tissue.
Patent DE-69621494-T2 (DE)
Inventor: DAVIDSON ANDREW E
IPC: G06F12/00
Filed: 1996-03-01
Granted: 2003-02-13
Abstract: A system and method for providing a distributed debugger system for a distributed target computer application are disclosed wherein the programmer/developer of the application can be at one host machine and wherein the application being developed makes use of objects and object implementations which may be located on a different host machine which is unknown to the programmer/developer. The system and method provides solutions to problems which are encountered in trying to debug a new application which is associated with the use of objects in a widely distributed, object oriented, client-server system. In a distributed object environment, requests and replies are made through an Object Request Broker (ORB) that is aware of the locations and status of objects. One architecture which is suitable for implementing such an ORB is provided by the Common Object Request Broker Architecture (CORBA) specification. The distributed debugger system disclosed herein is designed to function in a CORBA compliant distributed system. <IMAGE>
Patent DE-69625191-T2 (DE)
Inventor: VOSE R
IPC: A61K39/116
Filed: 1996-05-02
Granted: 2003-07-10
Abstract: Vaccine for protecting humans against Bordetella pertussis infection comprises pertussis toxoid (I), filamentous haemagglutinin (II), pertactin (III) and agglutinogens (IV) of B. pertussis in relative amts. able to confer protection to >= 70% of an at-risk population. A single dose is 5-30 mu g (I) and (II), 3-15 mu g (III) and 1-10 mu g (IV), all expressed as nitrogen contents, esp. 10 mu g (I) and 5 mu g (II) or 20 mu g each of these, plus 5 mu g (III) and 3 mu g (IV). Vaccines are administered by subcutaneous or intramuscular injection. (IV) comprises fimbrial agglutinogens (Agg) 2 and 3 (pref. at ratio 1.5-2:1) but is free of Agg 1. These may also include diphtheria toxoid, pref. at 15 Lfs, and tetanus toxoid, pref. at 5 Lf, opt. also other non-Bordetella antigens. They can also include an adjuvant, specifically alum.
Patent DE-69630050-T2 (DE)
Inventor: MATKOVICH MARIO
IPC: B07C5/36
Filed: 1996-11-15
Granted: 2004-04-08
Abstract: An apparatus (1) for loading articles (2) onto a moving conveyor, the apparatus including (a) transport means (3a, 3 b, 3c) on the conveyor which includes holding means (5) adapted to engage at least a portion of an article (2) so as to hold the article (2) in connected relation with the conveyor, and (b) locating means (6) operable to cause an article (2) positioned thereon to move into a position in which it cant thereafter be engaged by the holding means (5); wherein the transport means (3a, 3b, 3c) and the locating means (6) are co-operable such that the article (2) can be caused to be moved on the locating means (6) with the transport means (3a, 3b, 3c to being engaged by the holding means (5).
Patent DE-69630291-T2 (DE)
Inventor: OESTERBERG THOMAS
IPC: A61K38/43
Filed: 1996-03-29
Granted: 2004-05-06
Abstract: PCT No. PCT/SE96/00419 Sec. 371 Date Nov. 26, 1997 Sec. 102(e) Date Nov. 26, 1997 PCT Filed Mar. 9, 1996 PCT Pub. No. WO96/30041 PCT Pub. Date Oct. 3, 1996A final drug product comprises a plasma protein selected from the group consisting of coagulation factor VIII and factor IX, in an aqueous solution. The concentration of oxygen in the solution is reduced and/or the solution contains an antioxidant. The solution further contains a carbohydrate in a concentration of at least 350 mg/ml. The protein activity after storage for at least 6 months at a temperature of from 0 DEG  C. to 40 DEG  C. is from 70% to 130% of its initial value. In a process for preparing the final drug product and a method for improving the long-term stability of coagulation factor VIII or factor IX in an aqueous solution, a carbohydrate is included in the solution in a concentration of at least 350 mg/ml and the solution is stored in its final container under an oxygen-reduced atmosphere or includes an antioxidant.
Patent DE-69633281-T2 (DE)
Inventor: FENICAL WILLIAM H
IPC: A61K31/70
Filed: 1996-06-04
Granted: 2005-09-15
Abstract: Methods for treating mammals to reduce pain and/or reduce inflammation are described based on administering to the mammals synthetic ether derivatives of pseudopterosin having the formula:   <IMAGE>   wherein A is an alkyl, aryl or amide group having from 2 to 20 carbon atoms, R1, R2 and R3 are hydrogen or an acyl residue (-COR) having from 1 to 6 carbon atoms, R4 is hydrogen or -CH2OH and R5 is a hydrocarbon having from 1 to 10 carbon atoms. Also disclosed are synthetic compositions having the above general formula which are useful in the described method.
Patent DE-69635346-T2 (DE)
IPC: C12N15/19
Filed: 1996-06-05
Granted: 2006-07-27
Abstract: A process for producing a cloned macrophage activating factor (GcMAFc) comprises the steps of:  a) cloning a Gc1 isoform into a baculovirus vector; b) expressing the cloned Gc1 isoform thereby producing the cloned protein (Gc1), wherein the Gc1 protein comprises approximately 458 amino acids with a molecular weight of approximately 52000 Da and three distinct domains, c) contacting cloned Gc protein in vitro with immobilized  beta -galactosidase and sialidase; and d) obtaining the cloned macrophage activating factor (GcMAFc).  <IMAGE>
Patent DE-69636734-T2 (DE)
Inventor: SCHINAZI F
IPC: A61K38/21
Filed: 1996-06-07
Granted: 2007-10-18
Abstract: A method for the treatment of a host, and in particular, a human, infected with HB V is provided that includes administering an HBV-treatment amount of the stabilized nucleotide of a nucleoside which exhibits anti-hepatitis B activity.